Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,532 | 168 | 99.2% |
| Education | $38.77 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $1,326 | 25 | $0 (2024) |
| Boston Scientific Corporation | $747.43 | 21 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $294.52 | 21 | $0 (2024) |
| PAINTEQ LLC | $191.01 | 5 | $0 (2024) |
| Saluda Medical Americas, Inc. | $160.61 | 4 | $0 (2024) |
| Flexion Therapeutics, Inc. | $159.44 | 9 | $0 (2020) |
| GRT US Holding, Inc. | $143.29 | 3 | $0 (2022) |
| Amgen Inc. | $141.08 | 3 | $0 (2022) |
| Assertio Therapeutics, Inc. | $140.80 | 4 | $0 (2018) |
| Purdue Pharma L.P. | $110.21 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $581.75 | 22 | Saluda Medical Americas, Inc. ($160.61) |
| 2023 | $451.92 | 19 | Boston Scientific Corporation ($172.98) |
| 2022 | $598.93 | 21 | Boston Scientific Corporation ($136.49) |
| 2021 | $635.62 | 24 | Nevro Corp. ($269.70) |
| 2020 | $88.02 | 5 | PFIZER INC. ($32.64) |
| 2019 | $891.24 | 30 | Nevro Corp. ($534.37) |
| 2018 | $572.21 | 21 | Assertio Therapeutics, Inc. ($140.80) |
| 2017 | $750.85 | 28 | BOSTON SCIENTIFIC CORPORATION ($230.55) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $102.96 | General |
| Category: General - Therapies_NMD | ||||||
| 11/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: General - Therapies_NMD | ||||||
| 11/04/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/28/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/19/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Education | In-kind items and services | $22.34 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/30/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $50.92 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/30/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $45.26 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/11/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/30/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/29/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 05/09/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Education | In-kind items and services | $16.43 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/01/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.26 | General |
| Category: Opioid Analgesic | ||||||
| 04/11/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| Category: Opioid Analgesic | ||||||
| 03/21/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/05/2024 | Avanos Medical | COOLIEF* COOLED RADIOFREQUENCY (Device) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/14/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Spinal Cord Stimulator | ||||||
| 02/07/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $40.09 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/07/2024 | Avanos Medical | COOLIEF* COOLED RADIOFREQUENCY (Device) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/02/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $41.65 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/10/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.10 | General |
| Category: Opioid Analgesic | ||||||
| 01/09/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/12/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $141.04 | General |
| Category: General - Therapies_NMD | ||||||
| 10/12/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: General - Therapies_NMD | ||||||
| 08/02/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: General - Pain Management_NMD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 434 | 602 | $473,494 | $46,034 |
| 2022 | 15 | 469 | 858 | $633,639 | $54,403 |
| 2021 | 17 | 708 | 1,186 | $772,120 | $73,842 |
| 2020 | 16 | 699 | 896 | $611,915 | $56,038 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 40 | 43 | $19,307 | $8,375 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 135 | $41,952 | $6,392 | 15.2% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 32 | 34 | $12,036 | $5,218 | 43.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 70 | 84 | $29,988 | $5,116 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 73 | $33,986 | $4,737 | 13.9% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 31 | 51 | $136,119 | $4,642 | 3.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 16 | 32 | $73,776 | $3,980 | 5.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $19,638 | $2,607 | 13.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 29 | 66 | $53,900 | $2,502 | 4.6% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 12 | 17 | $49,385 | $2,095 | 4.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 13 | 29 | $1,392 | $257.39 | 18.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 13 | 13 | $2,015 | $112.80 | 5.6% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 55 | 66 | $23,364 | $10,083 | 43.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 40 | 82 | $218,858 | $6,814 | 3.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 108 | $34,794 | $5,570 | 16.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 76 | 90 | $32,130 | $5,471 | 17.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 74 | $35,932 | $4,991 | 13.9% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 22 | 22 | $9,878 | $4,301 | 43.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 11 | 83 | $20,501 | $3,375 | 16.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2022 | 13 | 26 | $75,530 | $2,835 | 3.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 15 | 27 | $56,249 | $2,678 | 4.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 13 | 95 | $19,285 | $2,132 | 11.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 28 | 57 | $44,660 | $2,100 | 4.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 12 | 20 | $32,486 | $1,322 | 4.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $9,240 | $1,122 | 12.1% |
About Dr. Paul Lafavore, MD
Dr. Paul Lafavore, MD is a Anesthesiology healthcare provider based in Hickory, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568442762.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Lafavore, MD has received a total of $4,571 in payments from pharmaceutical and medical device companies, with $581.75 received in 2024. These payments were reported across 170 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($4,532).
As a Medicare-enrolled provider, Lafavore has provided services to 2,310 Medicare beneficiaries, totaling 3,542 services with total Medicare billing of $230,316. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine
- Location Hickory, NC
- Active Since 01/23/2006
- Last Updated 07/01/2011
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1568442762
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $896.01
- Omnia (Device) $398.95
- XTAMPZA (Drug) $240.27
- GENERAL - PAIN MANAGEMENT (Device) $219.75
- PAINTEQ (Device) $191.01
- Evoke (Device) $160.61
- Zilretta (Drug) $159.44
- General - Pain Management (Device) $154.78
- Qutenza (Drug) $143.29
- Gralise (Drug) $140.80
- Xeomin (Biological) $65.81
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $59.28
- Horizant (Drug) $44.25
- WaveWriter Alpha Prime 16 (Device) $43.05
- Aimovig (Biological) $41.93
- COOLIEF* COOLED RADIOFREQUENCY (Device) $40.93
- LYRICA (Drug) $40.86
- INTELLIS (Device) $37.39
- Proclaim IPG (Device) $36.30
- Amitiza (Drug) $34.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Hickory
Dr. Michelle Brown, Md, MD
Anesthesiology — Payments: $411,324
Dr. Glenn Paige, Md, MD
Anesthesiology — Payments: $82,404
Dr. Christopher Hunt, Md, MD
Anesthesiology — Payments: $10,482
Dr. Donald Brown, Md, MD
Anesthesiology — Payments: $3,033
Dr. Felicia Cain, Md, MD
Anesthesiology — Payments: $1,156
Dr. Christopher Lariscy, Md, MD
Anesthesiology — Payments: $1,083